In the closing weeks of Belmont’s regular season, senior pitcher Maya Johnson stalks the mound with the confidence of a veteran. Over the past two years she has posted a minuscule .66 ERA and racked up 381 strikeouts, leading the NCAA in every major pitching metric. Her dominance helped Belmont clinch a dramatic 11‑10 win over rival Lipscomb, where she closed the game with three consecutive strikeouts.

Diagnosed with lupus at 15, Johnson endured years of fatigue, joint pain and a hospitalised flare that threatened her career. Intensive therapy—ultrasound, electrical stimulation and a continuous glucose monitor—now keeps her symptoms in check, allowing her to train without the excessive rest most athletes need. Her condition forced University of Pittsburgh’s coaching staff to refuse clearance, prompting a redshirt year and a transfer search.

Belmont relies on Johnson’s stamina as they head into postseason play; her ability to dominate hitters while managing a chronic illness gives the Bruins a rare competitive edge. Opponents now face a pitcher who can sustain sub‑one ERA innings despite limited practice time. Johnson’s story also highlights the broader conversation about medical transparency in college recruiting.